Critical hematological parameters in bleeding during extracorporeal membrane oxygenation support

Area of Science:

• Cardiovascular Medicine
• Hematology
• Critical Care Medicine

Background:

• Bleeding complications are frequent in patients on extracorporeal membrane oxygenation (ECMO).
• Managing bleeding during ECMO is challenging due to complex underlying mechanisms.
• Conventional coagulation tests often fail to predict bleeding risk accurately in these patients.

Purpose of the Study:

• To highlight the role of acquired von Willebrand syndrome (AVWS) in ECMO-associated bleeding.
• To emphasize the limitations of standard coagulation parameters in predicting bleeding during ECMO.
• To advocate for the evaluation of AVWS in bleeding ECMO patients.

Main Methods:

• This study reviews the pathophysiology of AVWS in the context of ECMO.
• It analyzes the inadequacy of conventional coagulation assays in identifying bleeding risks.
• It discusses the importance of assessing von Willebrand factor (vWF) function.

Main Results:

• Acquired von Willebrand syndrome (AVWS) is a significant contributor to bleeding in ECMO patients.
• AVWS involves a reduced affinity of von Willebrand factor (vWF) for platelets and collagen.
• Standard coagulation profiles do not typically include vWF assessment, leading to underdiagnosis of AVWS.

Conclusions:

• Physicians should consider evaluating for AVWS in patients experiencing bleeding while on ECMO support.
• Assessing vWF is crucial for a comprehensive understanding of bleeding risks in ECMO.
• Early identification and management of AVWS can potentially improve outcomes for ECMO patients.